The data will be filed with regulatory authorities to seek an expansion of the label for Nubeqa, according to Bayer ... Nubeqa is one of three drugs that the company is hoping will help it ...
Bayer stated that sales of Nubeqa exceeded 1 billion euros year to date in September ... Bayer is working on the label expansion of its approved drugs and simultaneously developing new drugs.
Bayer stated that sales of Nubeqa exceeded 1 billion euros year to date in September 2024. Prostate cancer is the second most common cancer in men and the fifth most common cause of cancer-induced ...